| # | Drug | Count |
|---|---|---|
| 0 | BLEOMYCIN | 2 |
| 1 | BLEOMYCIN SULFATE | 2 |
| 2 | METHOTREXATE | 2 |
| 3 | METHOTREXATE SODIUM | 2 |
| 4 | CISPLATIN | 1 |
| 5 | CYCLOPHOSPHAMIDE | 1 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 1 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1 |
| 8 | CYTARABINE | 1 |
| 9 | ETOPOSIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROCARBAZINE HYDROCHLORIDE | 1 | 0.0002 |
| 1 | BLEOMYCIN SULFATE | 2 | 0.0002 |
| 2 | MERCAPTOPURINE | 1 | 0.0001 |
| 3 | CYTARABINE | 1 | 0.0000 |
| 4 | ETOPOSIDE | 1 | 0.0000 |
| 5 | CISPLATIN | 1 | 0.0000 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 1 | 0.0000 |
| 7 | CYCLOPHOSPHAMIDE | 1 | 0.0000 |
| 8 | PREDNISOLONE ORAL SOLUTION | 1 | 0.0000 |
| 9 | METHOTREXATE SODIUM | 2 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 2 |
| 1 | Alkylating Drug [EPC] | 1 |
| 2 | Corticosteroid [EPC] | 1 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1 |
| 4 | Platinum-based Drug [EPC] | 1 |
| 5 | Topoisomerase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Corticosteroid [EPC] | 1 | 0.0000 |